Neumora Therapeutics, Inc. Common Stock (NMRA) vs Rallybio Corporation (RLYB)

A side-by-side comparison of Neumora Therapeutics, Inc. Common Stock and Rallybio Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Neumora Therapeutics, Inc. Common Stock logo
NMRA
Neumora Therapeutics, Inc. Common Stock
$90M
$0.48HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT
Rallybio Corporation logo
RLYB
Rallybio Corporation
$89M
$16.84HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT

Total return — NMRA vs RLYB

growth of $100 · dividends reinvested · last 3y
NMRA -96.8% (-68.1%/yr)RLYB -57.2% (-24.6%/yr)RLYB compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202420252026$3$43
NMRA RLYB

NMRA vs RLYB: by the numbers

  • •NMRA is the larger company ($90M vs $89M market cap).
  • •RLYB is profitable (7051.24% net margin) while NMRA runs a net loss (0.00%).

Metrics side by side

Valuation

MetricNMRARLYB
P/E ratioN/A2.16
P/S ratioN/A138.36
P/B ratio2.010.95
FCF yieldN/A29.47%

Profitability

MetricNMRARLYB
Gross margin0.00%89.28%
Operating margin0.00%-3270.86%
Net margin0.00%7051.24%
ROE-477.87%48.20%
ROIC-216.05%-24.40%

Growth (annualized)

MetricNMRARLYB
Total return CAGR (5Y)N/A-35.80%

Frequently asked

Is NMRA or RLYB more profitable?
RLYB runs the higher net margin — NMRA at 0.00% versus RLYB at 7051.24%.

Go deeper

Full NMRA analysisFull RLYB analysisInteractive comparison tool

Dig into the metrics

Rallybio P/E ratioNeumora Therapeutics, Inc. Common Stock ROERallybio ROENeumora Therapeutics, Inc. Common Stock operating marginRallybio operating marginNeumora Therapeutics, Inc. Common Stock revenue growthRallybio revenue growthNeumora Therapeutics, Inc. Common Stock free cash flowRallybio free cash flow

Neumora Therapeutics, Inc. Common Stock & Rallybio appear in these rankings

Highest ROE StocksHighest FCF Yield StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.